-

Global Protein Sequencing Market Drivers, Restraints & Opportunities During the Forecast Period, 2019-2026 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Protein Sequencing Market by Product and Service Technology and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

The global protein sequencing market size was valued at $ 5,399.9 million in 2018 and is expected to reach $ 9,926.7 million by 2026, registering a CAGR of 7.8% from 2019 to 2026.

Protein sequencing provides information regarding the amino acids that make up a protein. While performing the sequencing process, amino acids are sequentially removed from the N-terminal end of the protein strand and identified in the order they occur in the protein. Protein sequencing finds its wide applications in the field of genetic engineering, and biotherapeutics. There are two main technologies available for protein sequencing namely Edman degradation and mass spectrometry. Edman degradation is considered as the gold standard for protein sequencing.

The major factors contributing to the growth of the protein sequencing market include surge in focus on biotherapeutics development biotechnology and pharmaceutical companies in various developing and developed regions. Technological advancements in de novo peptide-sequencing methods and analytical methods, with the application of neural networks, have opened new avenues in the market. However, high cost of infrastructures and the required equipment such as mass spectrometers, hamper the market growth. On the contrary, technological advancements for the identification of isobaric residues in protein sequences are expected to create lucrative opportunities in the near future.

KEY BENEFITS FOR STAKEHOLDERS

  • The protein sequencing market share and analysis is based on a comprehensive analysis of key developments in the industry.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
  • The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
  • The global protein sequencing market trends are studied from 2018 to 2026.
  • Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided.
  • Porter's five forces analysis illustrates the potency of buyers and suppliers operating in the protein sequencing industry.
  • The quantitative analysis of the global protein sequencing market from 2019 to 2026 is provided to determine the market potential.

Key Findings of the Protein Sequencing Market:

  • By product & service, the reagent & consumables segment accounted for the highest market share of 57% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
  • By region, North America was the major shareholder and accounted for the highest share of 40% in 2018.
  • By application, the biopharmaceuticals segment is expected to grow at a CAGR of 8.5% during the forecast period.
  • By end user, the biotechnology & pharmaceutical company segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.
  • Comprehensive competitive analysis and profiles of major market players such as Bioinformatics Solutions Inc., Charles River Laboratories, Agilent Technologies, Inc., Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters Corporation are provided in this report.

Key Topics Covered:

Chapter 1: Introduction

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Research Methodology

1.3.1. Secondary Research

1.3.2. Primary Research

1.3.3. Analyst Tools & Models

Chapter 2: Executive Summary

2.1. CXO Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope

3.2. Porter's Five Forces Analysis

3.3. Market Share Analysis

3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increasing Focus On Target-Based Drug Development

3.4.1.2. Advancements In Mass Spectrometry And Analytical Techniques

3.4.2. Restraints

3.4.2.1. Dearth Of Skilled Researchers And Laboratory Professionals

3.4.3. Opportunities

3.4.3.1. Opportunity In Computational Proteomics

Chapter 4: Protein Sequencing Market, By Products & Services

4.1. Overview

4.2. Reagents & Consumables

4.3. Instruments

4.4. Analysis Product

4.5. Protein Sequencing Services

Chapter 5: Protein Sequencing Market, By Technology

5.1. Overview

5.2. Mass Spectrometry

5.3. Edman Degradation

Chapter 6: Protein Sequencing Market, By Application

6.1. Overview

6.2. Biopharmaceuticals

6.3. Biotechnology Research

Chapter 7: Protein Sequencing Market By Region

7.1. Overview

7.2. North America

7.3. Europe

7.4. Asia-Pacific

7.5. LAMEA

Chapter 8: Company Profiles

8.1. Charles River Laboratories

8.2. Shimadzu Corp.

8.3. Agilent Technologies

8.4. Thermo Fischer Inc.

8.5. Selvita

8.6. Rapid Novor.

8.7. Sgs

8.8. Proteome Factory

8.9. Bioinformatics Solution

8.10. Water Corporation

For more information about this report visit https://www.researchandmarkets.com/r/tahl8q

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom